Last updated on March 2019

Investigation of the Effect of Nintedanib on the Pharmacokinetics of a Combination of Ethinylestradiol and Levonorgestrel in Patients With Non-small Cell Lung Cancer


Brief description of study

Investigate the effect of multiple oral doses of nintedanib on the single dose kinetics of a combination of ethinylestradiol and levonorgestrel (Microgynon®)

Detailed Study Description

Purpose:

Clinical Study Identifier: NCT02751385

Contact Investigators or Research Sites near you

Start Over

Boehringer Ingelheim Call Center

Klinikum Chemnitz gGmbH
Chemnitz, Germany

Boehringer Ingelheim Call Center

Medizinische Hochschule Hannover
Hannover, Germany

Boehringer Ingelheim Call Center

Universit tsklinikum des Saarlandes
Homburg/Saar, Germany

Boehringer Ingelheim Call Center

Praxis Dr. Gessner, Leipzig
Leipzig, Germany

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.